{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:40:38Z","timestamp":1793194838434,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"vor","delay-in-days":887,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41379-020-0510-7","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T10:03:24Z","timestamp":1583143404000},"page":"1466-1474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9190-2450","authenticated-orcid":false,"given":"Erik A.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikunj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9155-556X","authenticated-orcid":false,"given":"Meagan","family":"Montesion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean C.","family":"Pavlick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan S.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Venstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Elvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Y.","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0510-7_bib1","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-020-0510-7_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/pcmr.12560","article-title":"Kinase gene fusions in defined subsets of melanoma","volume":"30","author":"Turner","year":"2017","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/s41379-020-0510-7_bib4","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/PAS.0000000000001070","article-title":"Primary and metastatic melanoma with NTRK fusions","volume":"42","author":"Lezcano","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib5","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/1078-0432.CCR-14-0058","article-title":"Melanoma BRAF fusions-letter","volume":"20","author":"Botton","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0510-7_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm.2166","article-title":"Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma","volume":"16","author":"Palanisamy","year":"2010","journal-title":"Nat Med."},{"key":"10.1038\/s41379-020-0510-7_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep27454","article-title":"CRAF R391W is a melanoma driver oncogene","volume":"6","author":"Atefi","year":"2016","journal-title":"Sci Rep."},{"key":"10.1038\/s41379-020-0510-7_bib8","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1172\/JCI123089","article-title":"Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion","volume":"129","author":"McEvoy","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1038\/s41379-020-0510-7_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PAS.0000000000000387","article-title":"Clinical, histopathologic, and genomic features of spitz tumors with ALK fusions","volume":"39","author":"Yeh","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/PAS.0000000000000761","article-title":"A comparison of morphologic and molecular features of BRAF, ALK, and NTRK1 fusion spitzoid neoplasms","volume":"41","author":"Amin","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4116","article-title":"Kinase fusions are frequent in Spitz tumours and spitzoid melanomas","volume":"5","author":"Wiesner","year":"2014","journal-title":"Nat Commun."},{"key":"10.1038\/s41379-020-0510-7_bib12","unstructured":"Barnhill RL, Bahrami A, Bastian BC, Busam K, Cerroni L, de la Fouchardiere A, et al. Malignant Spitz tumour (Spitz melanoma). In: Elder D, Massi D, Scolyer R, et al., editors. World Health Organization 2018 Classification of Skin Tumours. Lyon, France: International Agency for Research on Cancer, 2018. p. 108\u201310."},{"key":"10.1038\/s41379-020-0510-7_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pathol.2015.12.007","article-title":"Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy","volume":"48","author":"Wiesner","year":"2016","journal-title":"Pathology."},{"key":"10.1038\/s41379-020-0510-7_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.4775","article-title":"NTRK3 kinase fusions in Spitz tumours","volume":"240","author":"Yeh","year":"2016","journal-title":"J Pathol."},{"key":"10.1038\/s41379-020-0510-7_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0000000000001235","article-title":"Filigree-like rete ridges, lobulated nests, rosette-like structures, and exaggerated maturation characterize Spitz tumors With NTRK1 fusion","volume":"43","author":"Yeh","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/1066896916630375","article-title":"Spitz tumors: comparison of histological features in relationship to immunohistochemical staining for ALK and NTRK1","volume":"24","author":"Kiuru","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/PAS.0000000000001074","article-title":"Genomic fusions in pigmented spindle cell nevus of reed","volume":"42","author":"Vandenboom","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib18","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","article-title":"BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition","volume":"19","author":"Hutchinson","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0510-7_bib19","doi-asserted-by":"crossref","first-page":"6632","DOI":"10.1158\/1078-0432.CCR-14-1152","article-title":"Melanoma BRAF fusions-response","volume":"20","author":"Hutchinson","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0510-7_bib20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/PAS.0000000000001362","article-title":"Pathologic characteristics of Spitz melanoma with MAP3K8 fusion or truncation in a pediatric cohort","volume":"43","author":"Newman","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00138","article-title":"Significant clinical response to a MEK inhibitor therapy in a patient with metastatic melanoma harboring an RAF1 fusion","volume":"2","author":"Kim","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1038\/s41379-020-0510-7_bib22","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nbt.2696","article-title":"Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing","volume":"31","author":"Frampton","year":"2013","journal-title":"Nat Biotechnol."},{"key":"10.1038\/s41379-020-0510-7_bib23","doi-asserted-by":"crossref","unstructured":"Sun JX, He Y, Sanford E, Montesion M, Frampton GM, Vignot S, et al. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal. PLoS Pathog. 2018;14:e1005965.","DOI":"10.1371\/journal.pcbi.1005965"},{"key":"10.1038\/s41379-020-0510-7_bib24","doi-asserted-by":"crossref","unstructured":"Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34.","DOI":"10.1186\/s13073-017-0424-2"},{"key":"10.1038\/s41379-020-0510-7_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jmoldx.2019.06.011","article-title":"A novel next-generation sequencing approach to detecting microsatellite instability and pan-tumor characterization of 1000 microsatellite instability-high cases in 67,000 patient samples","volume":"21","author":"Trabucco","year":"2019","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-020-0510-7_bib26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med."},{"key":"10.1038\/s41379-020-0510-7_bib27","doi-asserted-by":"crossref","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","DOI":"10.1038\/nature12477"},{"key":"10.1038\/s41379-020-0510-7_bib28","unstructured":"Elder DE, Barnhill RL, Bastian BC, Cook MG, de la Fouchardiere A, Gerami P, et al. Melanocytic Tumours. In: Elder D, Massi D, Scolyer R, et al., editors. World Health Organization 2018 Classification of Skin Tumours. Lyon, France: International Agency for Research on Cancer, 2018. p. 65\u201377."},{"key":"10.1038\/s41379-020-0510-7_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5846","article-title":"The landscape of kinase fusions in cancer","volume":"5","author":"Stransky","year":"2014","journal-title":"Nat Commun."},{"key":"10.1038\/s41379-020-0510-7_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature."},{"key":"10.1038\/s41379-020-0510-7_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jid.2018.07.045","article-title":"Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations","volume":"139","author":"Martins da Silva","year":"2019","journal-title":"J Invest Dermatol"},{"key":"10.1038\/s41379-020-0510-7_bib32","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/pcmr.12785","article-title":"Malignant melanoma with areas of rhabdomyosarcomatous differentiation arising in a giant congenital nevus with RAF1 gene fusion","volume":"32","author":"Baltres","year":"2019","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1038\/s41379-020-0510-7_bib33","doi-asserted-by":"crossref","unstructured":"Jones DTW, Kocialkowski S, Liu L, Pearson DM, Ichimura K, Collins VP. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene. 2009;28:2119\u201323.","DOI":"10.1038\/onc.2009.73"},{"key":"10.1038\/s41379-020-0510-7_bib34","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1038\/onc.2017.276","article-title":"CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles","volume":"36","author":"Jain","year":"2017","journal-title":"Oncogene."},{"key":"10.1038\/s41379-020-0510-7_bib35","doi-asserted-by":"crossref","unstructured":"Donati M, Kastnerova L, Martinek P, Grossmann P, Sticov\u00e1 E, Hadravsk\u00fd L, et al. Spitz tumors with ROS1 fusions: A clinicopathological study of 6 cases, including FISH for chromosomal copy number alterations and mutation analysis using next-generation sequencing. Am J Dermatopathol. 2019;42:92\u2013102.","DOI":"10.1097\/DAD.0000000000001499"},{"key":"10.1038\/s41379-020-0510-7_bib36","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0000000000000187","article-title":"Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions","volume":"38","author":"Busam","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-020-0510-7_bib37","doi-asserted-by":"crossref","unstructured":"Akbani R, Akdemir KC, Aksoy BA, Albert M, Ally A, Amin SB, et al. Genomic classification of cutaneous melanoma. Cell. 2015;161:1681\u201396.","DOI":"10.1016\/j.cell.2015.05.044"},{"key":"10.1038\/s41379-020-0510-7_bib38","doi-asserted-by":"crossref","first-page":"9214","DOI":"10.1073\/pnas.95.16.9214","article-title":"Autoregulation of the Raf-1 serine\/threonine kinase","volume":"95","author":"Cutler","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/s41379-020-0510-7_bib39","first-page":"1","article-title":"TERT promoter mutations are predictive of aggressive clinical behavior in patients with Spitzoid melanocytic neoplasms","volume":"5","author":"Lee","year":"2015","journal-title":"Sci Rep."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0510-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200789X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522200789X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0510-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:41:06Z","timestamp":1760229666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522200789X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S089339522200789X"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0510-7","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0510-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors.","name":"copyright","label":"Copyright"}]}}